← check another ticker
RXRX
Recursion Pharmaceuticals, Inc.
7
Pretty Regarded
Regard Score: 7/10
$3.92$2.1B market cap

Score Breakdown

🤖AI Rating
6/10

Below average.

💸Valuation
5/10

Negative cash flow. Can't value it.

P/S: 31.3x
TTM Growth: -56.1%
🔍Filing Risk
5/10

Some yellow flags.

Overall Risk: 5/10
Fraud Risk: 0/10
Dilution Risk: 0/10
🖨️Dilution
7/10

Shares melting fast.

Annual Dilution: +31.4%
🏃Insider Selling
4/10

Neutral.

Signal:
⏳Cash Runway
7/10

Tight but ok.

Months Left: 24
🩳Short Interest
9/10

Heavy bearish bets.

% of Float Shorted: 52.8%
Days to Cover: 8.4
🤡Management
5/10

No data.

Exec Pay (% Rev): 79.9%
🔔 Want to know when RXRX stops being regarded?
Get an email when the regard score changes.
No spam, just alerts.